Bank of America’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.57M | Buy |
1,320,130
+765,702
| +138% | +$2.65M | ﹤0.01% | 3397 |
|
2025
Q1 | $1.45M | Buy |
554,428
+97,134
| +21% | +$254K | ﹤0.01% | 4140 |
|
2024
Q4 | $1.88M | Sell |
457,294
-794,029
| -63% | -$3.27M | ﹤0.01% | 3789 |
|
2024
Q3 | $8.86M | Buy |
1,251,323
+455,841
| +57% | +$3.23M | ﹤0.01% | 2718 |
|
2024
Q2 | $5.19M | Buy |
795,482
+53,779
| +7% | +$351K | ﹤0.01% | 3070 |
|
2024
Q1 | $6.16M | Buy |
741,703
+429,513
| +138% | +$3.56M | ﹤0.01% | 2907 |
|
2023
Q4 | $3.44M | Buy |
312,190
+47,836
| +18% | +$527K | ﹤0.01% | 3217 |
|
2023
Q3 | $2.22M | Sell |
264,354
-114,402
| -30% | -$962K | ﹤0.01% | 3469 |
|
2023
Q2 | $4.76M | Sell |
378,756
-247,147
| -39% | -$3.1M | ﹤0.01% | 2918 |
|
2023
Q1 | $10.3M | Buy |
625,903
+271,414
| +77% | +$4.47M | ﹤0.01% | 2394 |
|
2022
Q4 | $5.3M | Buy |
354,489
+202,463
| +133% | +$3.02M | ﹤0.01% | 2854 |
|
2022
Q3 | $3.4M | Buy |
152,026
+30,665
| +25% | +$686K | ﹤0.01% | 3192 |
|
2022
Q2 | $2.03M | Buy |
121,361
+36,542
| +43% | +$612K | ﹤0.01% | 3695 |
|
2022
Q1 | $2.54M | Sell |
84,819
-68,325
| -45% | -$2.04M | ﹤0.01% | 3779 |
|
2021
Q4 | $4.7M | Buy |
153,144
+116,834
| +322% | +$3.59M | ﹤0.01% | 3177 |
|
2021
Q3 | $1.15M | Sell |
36,310
-24,986
| -41% | -$788K | ﹤0.01% | 4229 |
|
2021
Q2 | $2.24M | Buy |
61,296
+22,165
| +57% | +$811K | ﹤0.01% | 3649 |
|
2021
Q1 | $1.35M | Buy |
39,131
+30,692
| +364% | +$1.06M | ﹤0.01% | 4024 |
|
2020
Q4 | $350K | Buy |
8,439
+7,204
| +583% | +$299K | ﹤0.01% | 4547 |
|
2020
Q3 | $53K | Buy |
+1,235
| New | +$53K | ﹤0.01% | 5339 |
|